Antiphospholipid syndrome (APS) is diagnosed in the presence of vascular thrombosis or pregnancy morbidity occurring in patients with circulating antiphospholipid antibodies (lupus anticoagulant [LA] and/or IgG/IgM anticardiolipin [aCL] and/or IgG/IgM anti-β2glycoprotein I [aβ2GPI] antibodies). Each test may identify different autoantibodies; a single test makes the diagnosis possible when positive on two or more occasions at least 12 weeks apart. However, single test positivity may be unrelated to pathogenic antibodies, which are now considered to be a subclass of aβ2GPI antibodies directed against the domain I of this protein. Conversely, all three positive tests identify a single class of aβ2GPI antibodies, thus identifying high-risk patients with APS.
Miyakis S., Lockshin MD, Atsumi M., et al. International consensus statement on an update of the classification criteria for definite antiphospholipid syndrome (APS). J Thromb Haemost2006; 4: 295-306.
2.
Pengo V., Biasiolo A., Gresele P., et al. Survey of lupus anticoagulant diagnosis by central evaluation of positive plasma samples. J Thromb Haemost2007; 5: 925-930.
3.
Pengo V., Biasiolo A., Bison E., Chantarangkul V., Tripodi A.Antiphospholipid antibody ELISAs: survey on the performance of clinical laboratories assessed by using lyophilized affinity-purified IgG with anticardiolipin and anti-beta2-Glycoprotein I activity. Thromb Res2007; 120: 127-133.
4.
de Laat B., Derksen RH, Urbanus RT, de Groot PGIgG antibodies that recognize epitope Gly40-Arg43 in domain I of beta 2-glycoprotein I cause LA, and their presence correlates strongly with thrombosis. Blood2005; 105: 1540-1545.
5.
Pengo V., Biasiolo A.The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost2001; 86: 933.
6.
Galli M., Luciani D., Bertolini G., Barbui T.Lupus anticoagulants are stronger risk factors for thrombosis than anticardiolipin antibodies in the antiphospholipid syndrome: a systematic review of the literature . Blood2003; 101: 1827-1832.
7.
Galli M., Luciani B., Bertolini G., Barbui T.Anti-β2-Glycoprotein I, anti-prothrombin antibodies and the risk of thrombosis in the antiphospholipid syndrome. Blood2003 ; 102: 2717-2723.
8.
Garcia CO, Kanbour-Shakir A., Tang H., Molina JF, Espinoza LR, Gharavi AEInduction of experimental antiphospholipid antibody syndrome in PL/J mice following immunization with beta 2 GPI. Am J Reprod Immunol1997; 37: 118-124.
9.
Pengo V., Biasiolo A., Pegoraro C., Cucchini U., Noventa F., Iliceto S.Antibody profiles for the diagnosis of antiphospholipid syndrome. Thromb Haemost2005; 93: 147-152.
10.
Ruffatti A. , Tonello M., Del Ross T., et al. Antibody profile and clinical course in primary antiphospholipid syndrome with pregnancy morbidity. Thromb Haemost2006; 96: 337-341.
11.
Pengo V., Balestrieri G., Tincani A., Spatola L., Biasiolo A., Brocco T.Utilization of dilute Russell’s viper venom time to detect autoantibodies against beta 2-glycoprotein I which express anticoagulant activity in the presence but not in the absence of exogenous phospholipids. Thromb Haemost1997; 77: 123-126.
12.
de Laat B., Pengo V., Pabinger I., et al. The association between circulating antibodies against domain I of beta2-glycoprotein I and thrombosis: an international multicenter study . J Thromb Haemost2009; DOI 10.1111/j.1538-7836.2009.03588.
13.
Ruffatti A. , Olivieri S., Tonello M., et al. Influence of different IgG anticardiolipin antibody cut-off values on antiphospholipid syndrome classification. J Thromb Haemost2008; 6: 1693-1696.
14.
Arvieux J., Pernod G., Regnault V., Darnige L., Garin J.Some anticardiolipin antibodies recognize a combination of phospholipids with thrombin-modified antithrombin, complement C4b-binding protein, and lipopolysaccharide binding protein. Blood1999; 93: 4248-4255.
15.
Rampazzo P. , Biasiolo A., Garin J., et al. Some patients with antiphospholipid syndrome express hitherto undescribed antibodies to cardiolipin-binding proteins . Thromb Haemost2001; 85: 57-62.
16.
Pengo V., Biasiolo A.The risk of overdiagnosis of antiphospholipid antibody syndrome. Thromb Haemost2001; 86: 933.
Di Simone N. , Meroni PL, D’Asta M., et al. Pregnancies complicated with antiphospholipid syndrome: the pathogenic mechanism of antiphospholipid antibodies A review of the literature. Ann NY Acad Sci2007; 1108: 505-514.
19.
Girardi G., Berman J., Redecha P., et al. Complement C5a receptors and neutrophils mediate fetal injury in the antiphospholipid syndrome. J Clin Invest2003; 112: 1644-1654.
20.
Shamonki JM , Salmon JE, Hyjek E., Baergen RNExcessive complement activation is associated with placental injury in patients with antiphospholipid antibodies. Am J Obstet Gynecol2007; 196: 167.
21.
Erkan D., Lockshin MDWhat is antiphospholipid syndrome?Curr Rheumatol Rep2004; 6: 451-457.
22.
Ebelin F., Pettersson T., Muukkonen L., Vahtera E., Rasi V.β2-glycoprotein I antibodies in patients with thrombosis. Scand J Clin Lab2003; 63: 11-18.
23.
Myers B., Gould J.The place ofβ2-glycoprotein I in the assessment of antiphospholipid syndrome . Blood Coag Fibrinolysis2003; 14: 1-2.
24.
Pengo V., Biasiolo A., Gresele P., et al. A comparison of lupus anticoagulant-positive patients with clinical picture of antiphospholipid syndrome and those without. Arterioscler Thromb Vasc Biol2007; 27: 309-310.
25.
Pengo V., Ruffatti A., Legnani C., et al. Clinical course of high risk patients diagnosed with Antiphospholipid Syndrome (APS). J Thromb Haemost2009 Oct 30; [Epub ahead of print] PMID: 19874470 [PubMed - as supplied by publisher].
26.
Pengo V., Tripodi A., Reber G., et al. Update of the guidelines for lupus anticoagulant detection. J Thromb Haemost2009; 10: 1737-1740.
